Literature DB >> 10882144

Absence of response to human parathyroid hormone in athymic mice grafted with human parathyroid adenoma, hyperplasia or parathyroid cells maintained in culture.

B G Hory1, M C Roussanne, S Rostand, A Bourdeau, T B Drüeke, J Gogusev.   

Abstract

In athymic mice we have developed a model of long-term human PTH hypersecretion, using xenotransplantation of respectively parathyroid gland fragments obtained from patients with primary (primary) or secondary (secondary) uremic hyperparathyroidism (HPT), and parathyroid cells maintained in culture from patients with secondary uremic HPT. Both grafted parathyroid tissue fragments and cultured cells induced prolonged and marked secretion of human intact PTH (iPTH) in nude mice. Despite extremely high plasma iPTH levels, hypercalcemia or hypophosphatemia was not observed. Moreover, PTH secretion was not significantly modified by low-calcium, high-phosphate diet for 3 weeks. Four mice which had a mean plasma human iPTH level of 237+/-152 pg/ml for more than 9 months and 4 age-matched, sham-grafted control mice with undetectable human iPTH levels underwent bone histomorphometry examination. No difference was found between the two groups with respect to active bone resorption surface or number of osteoclasts/mm2. We hypothesize that the characteristic deficit of T cell function and of cytokine and growth factor production may protect nude mice with chronic hypersecretion of human PTH from hypercalcemia and bone lesions. We suggest that this strain of mice could be used for better understanding the relationship between cytokines and bone turnover.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882144     DOI: 10.1007/BF03343723

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  38 in total

1.  Parathyroid hormone/parathyroid hormone-related protein receptor expression in nude mice with a transplantable canine apocrine adenocarcinoma (CAC-8) and humoral hypercalcaemia of malignancy.

Authors:  A Gröne; L K McCauley; C C Capen; T J Rosol
Journal:  J Endocrinol       Date:  1997-04       Impact factor: 4.286

2.  The canine renal parathyroid hormone receptor is a glycoprotein: characterization and partial purification.

Authors:  D B Karpf; C D Arnaud; K King; T Bambino; J Winer; K Nyiredy; R A Nissenson
Journal:  Biochemistry       Date:  1987-12-01       Impact factor: 3.162

Review 3.  Primary hyperparathyroidism.

Authors:  A al Zahrani; M A Levine
Journal:  Lancet       Date:  1997-04-26       Impact factor: 79.321

4.  Loss of calcemic effects of calcitonin and parathyroid hormone infused continuously into rats using the Alzet osmotic minipump.

Authors:  J F Obie; C W Cooper
Journal:  J Pharmacol Exp Ther       Date:  1979-06       Impact factor: 4.030

5.  Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.

Authors:  S K Lee; J A Lorenzo
Journal:  Endocrinology       Date:  1999-08       Impact factor: 4.736

6.  Primary hyperparathyroidism: a new experimental animal model.

Authors:  P Schachter; N Buckley; H Oyama; M Christy; G Leight; B Lobaugh
Journal:  Surgery       Date:  1989-12       Impact factor: 3.982

7.  T lymphocytes play a critical role in the development of cyclosporin A-induced osteopenia.

Authors:  F J Buchinsky; Y Ma; G N Mann; B Rucinski; H P Bryer; D F Romero; W S Jee; S Epstein
Journal:  Endocrinology       Date:  1996-06       Impact factor: 4.736

8.  Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption--a clinical research center study.

Authors:  A Grey; M A Mitnick; S Shapses; A Ellison; C Gundberg; K Insogna
Journal:  J Clin Endocrinol Metab       Date:  1996-10       Impact factor: 5.958

9.  Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo.

Authors:  J de la Mata; H L Uy; T A Guise; B Story; B F Boyce; G R Mundy; G D Roodman
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

10.  Effects of infusion of human parathyroid hormone-related protein-(1-40) in nude mice: histomorphometric and biochemical investigations.

Authors:  T J Rosol; C C Capen; R L Horst
Journal:  J Bone Miner Res       Date:  1988-12       Impact factor: 6.741

View more
  14 in total

Review 1.  T cells: critical bone regulators in health and disease.

Authors:  Roberto Pacifici
Journal:  Bone       Date:  2010-05-07       Impact factor: 4.398

Review 2.  Parathyroid Diseases and T Cells.

Authors:  M Neale Weitzmann; Roberto Pacifici
Journal:  Curr Osteoporos Rep       Date:  2017-06       Impact factor: 5.096

Review 3.  The immune system and bone.

Authors:  Roberto Pacifici
Journal:  Arch Biochem Biophys       Date:  2010-06-17       Impact factor: 4.013

Review 4.  Bone and the Immune System.

Authors:  M Neale Weitzmann
Journal:  Toxicol Pathol       Date:  2017-10-18       Impact factor: 1.902

5.  Parathyroid hormone mediates hematopoietic cell expansion through interleukin-6.

Authors:  Flavia Q Pirih; Megan N Michalski; Sun W Cho; Amy J Koh; Janice E Berry; Eduardo Ghaname; Pachiyappan Kamarajan; Edith Bonnelye; Charles W Ross; Yvonne L Kapila; Pierre Jurdic; Laurie K McCauley
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

6.  Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss.

Authors:  Hesham Tawfeek; Brahmchetna Bedi; Jau-Yi Li; Jonathan Adams; Tatsuya Kobayashi; M Neale Weitzmann; Henry M Kronenberg; Roberto Pacifici
Journal:  PLoS One       Date:  2010-08-20       Impact factor: 3.240

7.  T cells potentiate PTH-induced cortical bone loss through CD40L signaling.

Authors:  Yuhao Gao; Xiaojun Wu; Masakazu Terauchi; Jau-Yi Li; Francesco Grassi; Sarah Galley; Xiaoying Yang; M Neale Weitzmann; Roberto Pacifici
Journal:  Cell Metab       Date:  2008-08       Impact factor: 27.287

Review 8.  Role of T cells in the modulation of PTH action: physiological and clinical significance.

Authors:  Roberto Pacifici
Journal:  Endocrine       Date:  2013-06-02       Impact factor: 3.633

Review 9.  T-cells and B-cells in osteoporosis.

Authors:  M Neale Weitzmann
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-12       Impact factor: 3.243

Review 10.  T cells, osteoblasts, and osteocytes: interacting lineages key for the bone anabolic and catabolic activities of parathyroid hormone.

Authors:  Roberto Pacifici
Journal:  Ann N Y Acad Sci       Date:  2015-12-10       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.